Literature DB >> 16480400

Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.

J F Bretagne1, C Honnorat, B Richard-Molard, A Caekaert, P Barthélemy.   

Abstract

BACKGROUND: Little is known about the distinctive characteristics of subjects with frequent (at least weekly) and occasional gastro-oesophageal reflux symptoms. AIM: To compare the characteristics and disease management of subjects complaining of at least weekly and less frequent gastro-oesophageal reflux symptoms.
METHODS: Population-based postal survey carried out in France in 2003 among a representative sample of 8000 subjects.
RESULTS: The prevalence of frequent and occasional gastro-oesophageal reflux symptoms was 7.8% and 23.4%, respectively. Compared to subjects with occasional gastro-oesophageal reflux symptoms, those with frequent symptoms were older, suffered from more severe symptoms and felt greater impact on daily living, despite a slightly shorter duration of symptoms. These subjects more often sought medical advice. Most of them had treated the last episode of symptoms primarily with a proton-pump inhibitor and less often with antacids/alginates. The degree of treatment satisfaction was lower in subjects with frequent gastro-oesophageal reflux symptoms, in relation to a more frequently observed persistence of symptoms irrespective of the medication used except for proton-pump inhibitors.
CONCLUSIONS: This survey suggests that subjects complaining of frequent or occasional gastro-oesophageal reflux symptoms constitute two distinctive groups. Despite greater healthcare use, the former group shows a lower level of satisfaction with disease management. Nevertheless, a substantial subset of subjects with occasional symptoms also complained of impaired health-related quality of life and sought health care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480400     DOI: 10.1111/j.1365-2036.2006.02811.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

1.  Gestational age at birth and risk of gastric acid-related disorders in young adulthood.

Authors:  Casey Crump; Marilyn A Winkleby; Jan Sundquist; Kristina Sundquist
Journal:  Ann Epidemiol       Date:  2012-03-03       Impact factor: 3.797

2.  Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement?

Authors:  William D Chey; Reema R Mody; Esin Izat
Journal:  Dig Dis Sci       Date:  2010-04-17       Impact factor: 3.199

3.  Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study.

Authors:  Alberto Zalar; Baya Haddouche; Michel Antonietti; Raied Alhameedi; Isabelle Iwanicki-Caron; Stéphane Lecleire; Philippe Ducrotté
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 4.  Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review.

Authors:  Sander Jo van Zanten; Catherine Henderson; Nesta Hughes
Journal:  Can J Gastroenterol       Date:  2012-04       Impact factor: 3.522

Review 5.  Esophageal impedance monitoring for gastroesophageal reflux.

Authors:  Hayat M Mousa; Rachel Rosen; Frederick W Woodley; Marina Orsi; Daneila Armas; Christophe Faure; John Fortunato; Judith O'connor; Beth Skaggs; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-02       Impact factor: 2.839

6.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

7.  Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement.

Authors:  Etienne Dorval; Jean-Francois Rey; Christine Soufflet; Katarina Halling; Philippe Barthélemy
Journal:  BMC Gastroenterol       Date:  2011-03-24       Impact factor: 3.067

Review 8.  The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.

Authors:  Helen F Boardman; Gordon Heeley
Journal:  Int J Clin Pharm       Date:  2015-06-23

9.  Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?

Authors:  Enrique Rey; Marta Barceló; Javier Zapardiel; Eduardo Sobreviela; Mercedes Muñoz; Manuel Díaz-Rubio
Journal:  BMC Gastroenterol       Date:  2014-01-22       Impact factor: 3.067

10.  Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy.

Authors:  Takashi Kawai; Yoji Hirayama; Aiko Oguchi; Fumi Ishii; Masanao Matushita; Naoya Kitayama; Shinji Morishita; Noboru Hiratsuka; Ken Ohata; Hiroyuki Konishi; Maiko Kishino; Shinichi Nakamura
Journal:  J Clin Biochem Nutr       Date:  2017-02-08       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.